Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
Clinical and Molecular Hepatology
;
: 183-187, 2016.
Article
in English
| WPRIM
| ID: wpr-46324
ABSTRACT
Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices can regress after such therapy. We report a case of complete regression of esophageal varices during entecavir therapy in patients with HBV-related liver cirrhosis, suggesting that complications of liver cirrhosis such as esophageal varices can regress after the long-term suppression of HBV replication.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
DNA, Viral
/
Esophageal and Gastric Varices
/
Hepatitis B virus
/
Polymerase Chain Reaction
/
Ultrasonography
/
Hepatitis B, Chronic
/
Abdomen
/
Guanine
/
Liver Cirrhosis
Type of study:
Diagnostic study
Limits:
Humans
/
Male
Language:
English
Journal:
Clinical and Molecular Hepatology
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS